Özlem ALTUNTAŞ AYDIN, Hayat KUMBASAR KARAOSMANOĞLU, Ramazan KORKUSUZ Mehmet ÖZEREN, Özcan NAZLICAN

Mucocutaneous manifestations and the relationship to CD4 lymphocyte counts among Turkish HIV/AIDS patients in İstanbul, Turkey

Dermatologic findings differ among countries but no sufficient data about Turkish HIV-infected patients exist in the literature. Therefore, our aim in this study was to document the dermatologic manifestations and their relationships with CD4 cell counts among HIV/AIDS patients visiting our clinic for the first time in İstanbul, Turkey. Materials and methods: A retrospective analysis of 306 HIV/AIDS patients (260 men, mean age: 38.3 years) was done in a tertiary hospital in İstanbul from January 2006 to September 2012. Information on age, sex, transmission routes, socioeconomic and educational status, CD4 counts, and dermatologic findings was collected retrospectively from medical records. Results: Our analyses revealed at least 1 dermatologic disease in 111 of the 306 (36.2%) patients. Mean CD4 count of the patients was 393.64 cells/mm3 (range: 4–1270 cells/mm3). Oral candidiasis (12.4%), herpes zoster (5.9%), dermatophytosis (5.4%), hyperpigmentation (5.2%), and folliculitis (4.6%) were the most common skin problems. Statistically significant correlation (P < 0.05) with low CD4 cell counts was found for oral candidiasis, folliculitis, herpes zoster, hyperpigmentation, xerosis, and Kaposi's sarcoma. Conclusion: Dermatologic manifestations in this study were identical to those described in most studies from Asia, and there were more manifestations as the HIV infection progressed and immune functions declined.

Anahtar Kelimeler:

Mucocutaneous findings, HIV/AIDS, CD4 lymphocyte counts

Mucocutaneous manifestations and the relationship to CD4 lymphocyte counts among Turkish HIV/AIDS patients in İstanbul, Turkey

Keywords:

Mucocutaneous findings, HIV/AIDS, CD4 lymphocyte counts,

PDF

___

Sud N, Shanker V, Sharma, A, Sharma NL, Gupta M. Mucocutaneous manifestations in 150 HIV-infected Indian patients and their relationship with CD4 lymphocyte counts. Int J STD AIDS 2009; 20: 771–774. 2. Sivayathorn A, Srihra B, Leesanguankul W. Prevalence of skin disease in patients infected human immunodeficiency virus in Bangkok, Thailand. Ann Acad Med Singapore 1995; 24: 528– 533.
Wiwanitkit V. Prevalence of dermatological disorders in Thai HIV-infected patients correlated with different CD4 lymphocyte count statuses: a note on 120 cases. Int J Dermatol 2004; 43: 265–268.
Foroughi M, Koochak HE, Roosta N, Paydary K, Khatami A, Shahriari S, Payvarmehr T, Seyed Alinaghi S. Prevalence of dermatologic manifestations among people living with HIV/ AIDS in Imam Khomeini Hospital in Tehran, Iran. J AIDS HIV Res 2012; 4: 56–59.
Cedeno-Laurent F, Gomez-Flores M, Mendez N, Ancer- Rodriquez J, Bryant JL, Gaspari AA, Trujillo JR. New insights into HIV-1-primary skin disorders. J Int AIDS Soc 2011; 14: 5.
Shobhana A, Guha SK, Neogi DK. Mucocutaneous manifestations in HIV infection. Indian J Dermatol Venereol Leprol 2004; 70: 82–86. 7. Josephine M, Issac E, George A, Ngole M, Albert SE. Patterns of skin manifestations and their relationships with CD4 counts among HIV/AIDS patients in Cameroon. Int J Dermatol 2006; 45: 280–284.
Boztepe G, Akoğlu G, Şahin GO, Güven GS, Ünal S, Şahin S. HIV/AIDS and skin: 7-year of experience at Hacettepe. Turk Derm 2006; 40: 46–51 (article in Turkish with English abstract).
Singh H, Singh P, Tiwari P, Dey V, Dulhani N, Singh A. Dermatological manifestations in HIV-infected patients at a tertiary care hospital in a tribal (Bastar) region of Chhattisgarh, India. Indian J Dermatol 2009; 54: 338–341.
Azfar NA, Khan AR, Zia MA, Humayun A, Malik LM, Jahangir M. Frequency of mucocutaneous manifestations in HIV positive Pakistani patients. J Pak Assoc Dermatol 2011; 21: 149–153.
Spira R, Mingard M, Doutre MS, Molart P, Dabis F. Prevalence of cutaneous disorders in a population of HIV-infected patients. Arch Dermatol 1998; 134: 1208–1212.
Esser S, Schoefer H. HIV-associated skin and mucocutaneous diseases. In: Hoffman C, Rockstroh JK, editors. HIV 2010. Hamburg, Germany: Medizin Fokus Verlag; 2010. pp. 568– 580.
Huang XJ, Li HY, Chen DX, Wang XC, Li ZC, Wu YS, Zhang T, Gao YQ, Wu H. Clinical analysis of skin lesions in 796 Chinese HIV-positive patients. Acta Derm Venerol 2011; 91: 552–556.
Kim TG, Lee KH, Oh SH. Skin disorders in Korean patients infected with human immunodeficiency virus and their association with a CD4 lymphocyte count: a preliminary study. J Eur Acad Venereol 2010; 24: 1476–1480.
Garbe C, Husak R, Orfanos CE. HIV-associated dermatoses and their prevalence in 456 HIV-infected patients. Relation to immune status and its importance as a diagnostic marker. Hautartz 1994; 45: 623–629.
Munoz-Perez MA, Rodriquez-Pichardo A, Camacho F, Colmenero MA. Dermatological findings correlated with CD4 lymphocyte counts in a prospective 3 year study of 1161 patients with human immunodeficiency virus disease predominantly acquired through intravenous drug abuse. Br J Dermatol 1998; 139: 33–39.
Jing W. A retrospective survey of mucocutaneous manifestations of HIV infection in Malaysia: analysis of 182 cases. J Dermatol 2000; 27: 225–232.
Goh BK, Chan RK, Sen P, Theng CT, Tan HH, Wu YJ, Paton NI. Spectrum of skin disorders in human immunodeficiency virus-infected patients in Singapore and the relationship to CD4 lymphocyte counts. Int J Dermatol 2007; 46: 695–699.
Franceschi S, Maso LD, Rickenbach M, Polosel J, Hirschel B, Cavassini M, Bordoni A, Elzi L, Ess S, Jundt G et al. Kaposi sarcoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy. Br J Cancer 2008; 99: 800–804.
Nnoruka EN, Chukwuka JC, Anisuiba B. Correlation of mucocutaneous manifestations of HIV/AIDS infection with CD4 counts and disease progression. Int J Dermatol 2007; 46: 14–18.